H
IDXX icon

Hexavest’s Idexx Laboratories IDXX Stock Holding History

Hexavest’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16
Closed -$10K – 264
2021
Q2 		$10K Sell
16
-1,870
-99% -$1.03M ﹤0.01% 311
2021
Q1 		$923K Buy
1,886
+1,822
+2,847% +$913K 0.04% 200
2020
Q4 		$32K Buy
64
+36
+129% +$16.1K ﹤0.01% 281
2020
Q3 		$11K Hold
28
– – ﹤0.01% 352
2020
Q2 		$9K Sell
28
-17
-38% -$4.92K ﹤0.01% 374
2020
Q1 		$11K Hold
45
– – ﹤0.01% 383
2019
Q4 		$12K Hold
45
– – ﹤0.01% 399
2019
Q3 		$12K Hold
45
– – ﹤0.01% 445
2019
Q2 		$12K Buy
+45
New +$11.1K ﹤0.01% 456

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hexavest's IDXX Position: Q3 2021 in Review

Hexavest sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 16 shares — an estimated $10K sold.

Hexavest first reported a position in IDXX in Q2 2019 and held it in 9 quarters. The position peaked at $923K in Q1 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

  • Hexavest reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
  • Hexavest sold 16 Idexx Laboratories shares in Q3 2021, an estimated $10K.
  • Hexavest first reported a position in Idexx Laboratories in Q2 2019 and held it in 9 quarters.
  • Hexavest's Idexx Laboratories position peaked at $923K in Q1 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Hexavest's 13F filing for Q3 2021, filed 27 Oct 2021.